# US 2003/0073675 A1 · Novel 19-norsteroids substituted in position 11beta, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0073675 A1
- Document ID: US20030073675A1
- Status: Published application
- Kind: A1
- Application number: 10/119,903
- Filed: 2002-04-10
- Published: 2003-04-17
- Earliest claimed: 1997-11-17
- Assignees: Aventis Pharma S.A.
- Inventors: Francois Nique
- Web page: https://patentgrep.com/patent/US20030073675A1

## CPC

- C07J 31/006: {not covered by C07J31/003}
- A61P 5/30: Oestrogens
- A61P 19/10: for osteoporosis
- C07J 41/0083: {substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings}
- C07J 43/003: {not condensed}
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07J: STEROIDS (seco-steroids C07C)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

A compound selected from the group consisting of a compound of the formula 1 wherein the substituents are defined as set forth in the specification which compounds are useful for the treatment of osteoporosis.

## Claims

### Claim 1

1) compounds of general formula (I):
22
in which:
R1 represents a hydrogen atom, a (CH2)m—Ar, (CO)—Ar, (CH2)m-Alk or (CO)-Alk radical,
R2 represents a radical derived from a, linear or branched, saturated or unsaturated hydrocarbure containing from 1 to 6 carbon atoms
D represents the residue of a pentagonal or hexagonal ring optionally substituted and optionally unsaturated,
X represents a halogen atom or a hydrogen atom, n is equal to 3, 4 or 5,
either identical or different R3 and R4 represent a hydrogen atom, a (CH2)m—Ar, (CH2)m-Het or (CH2)m-Alk group,
or R3 and R4 together with the nitrogen atom to which they are linked form a mono or polyclic, saturated or unsaturated, aromatic or non aromatic heterocycle, with 3 to 15 bonds optionally containing from 1 to 3 additional heteroatoms chosen from amongst non substituted or substituted oxygen, sulphur and nitrogen,
Ar represents a carbocyclic aryl group containing from 6 to 18 carbon atoms, Het represents an aromatic or non aromatic, saturated or unsaturated heterocycle comprising from 1 to 9 carbon atoms and from 1 to 5 heteroatoms chosen from amongst the atoms of oxygen, nitrogen or sulphur, Alk represents a radical derived from a non aromatic, linear, branched or cyclic, saturated or unsaturated hydrocarbure and comprising from 1 to 12 carbon atoms, the Ar radicals, Het or Alk able to be substituted or non substituted, m represents 0, 1, 2 or 3, as well as their addition salts with the bases or the acids.

### Claim 2 (depends on 1)

2) Compounds of general formula (I) as is described in claim 1, in which D represents the residue of a pentagonal ring of formula:
23
in which, R2 retains the same signification as in claim 1,
either R5 represents an OH, O—(CH2)m-Alk, O—(CO)-Alk, O—(CH2)m—Ar or O—(CO)—Ar, O—(CH2)m-Het, O—(CO)-Het, O—(CO)-Het and R6 represent a hydrogen atom, an alkyl, alkenyl or alkynyl radical containing from 1 to 6 substituted or non substituted carbon atoms, m, Alk, Ar and Het being as they are described in claim 1,
or R5 and R6 together with the carbon atom that carries them form one of the following rings:
24
in which Z represents a —(CH2)1— or —CH═CH—(CH2)1′ group, 1 being an integer between 1 and 4 and 1′being an integer equal to 1 or 2,
or R5 and R6 together form an oxo group, as well as their addition salts with the acids or the bases.

### Claim 3 (depends on 1, 2)

3) Compounds of general formula (I) as described in claim 1 or 2, corresponding to the general formula (I′):
25
in which:
X represents a chlorine, bromine or hydrogen atom, n′ is equal to 3,
either identical or different R′3 and R′4 represent an alkyl radical containing from 1 to 6 carbon atoms
or R′3 and R′4 together form, with the nitrogen atom to which they are linked, a saturated mono or polyclic residue with 3 to 15 bonds optionally containing an additional heteroatom chosen from amongst oxygen, sulphur and nitrogen,
R′5 and R′6 have the same meaning as R5 and R6, according to claim 2 as well as their addition salts with the acids and the bases.

### Claim 4 (depends on 3)

4) Compounds of general formula (I′) as described in claim 3, in which:
either R′5 represents an OH radical and R′6 represents a hydrogen atom, an alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms,
substituted or non substituted,
or R′5 and R′6 together with the carbon atom that carries them form one of the following rings:
26
or R′5 and R′6 together form an oxo group, as well as their addition salts with the acids or the bases.

### Claim 5 (depends on 3, 4)

5) Compounds of general formula (I′) as they are described in claim 3 or 4, in which:
X′ represents a chlorine or hydrogen atom,
either identical or different R′3 and R′4 represent an alkyl radical containing from 1 to 6 carbon atoms,
or R′3 and R′4 together with the nitrogen atom form the following saturated heterocycles:
27
and either R′5 represents an OH radical and R′6 represents a hydrogen atom,
an alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms,
substituted or non substituted,
or R′5 and R′6 together with the carbon atom that carries them form one of the following rings:
28
or R′5 and R′6 together form an oxo group, as well as their addition salts with the acids or the bases.

### Claim 6 (depends on 1, 2, 3, 4, 5)

6) Compounds of general formula (I) as they are described in any of the claims 1 to 5, in which X is a hydrogen atom.

### Claim 7 (depends on 1, 2, 3, 4, 5)

7) Compounds of general formula (I) as they are described in any of the claims 1 to 5, in which X is a chlorine atom.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

8) Compounds of formula (I) or (I′) as they are described in any of the claims 1 to 7, the names of which follow:
3-hydroxy-11β-[4-[3-(1-piperdinyl)propyl]phenyl]-estra-1.3.5(10)-trien-17-one,
3-hydroxy-11β-[4-[3-(1-pyrrolidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-17-one,
3-hydroxy-11β-[4-[3-dimethylamino)propyl]phenyl]-estra-1.3.5(10)-trien-17-one,
4-chloro-3-hydroxy-11β-[4-[3-(1-piperidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-17-one
4-chloro-3-hydroxy-11β-[4-[3-(1-pyrrolidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-17-one
4-chloro-3-hydroxy-11β-[4-[3-(diethylamino)propyl]phenyl]-estra-1.3.5(10)-trien-17-one
11β-[4-[3-(1-pyrrolidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-3.17β-diol,
11β-[4-(3-dimethylamino)propyl)phenyl]-estra-1.3.5(10)-trien-3.17β-diol
11β-[4-(1-piperidinyl)propyl)phenyl]-estra-1.3.5(10)-trien-3.17β-diol
4-chloro-11β-[4-[3-(1-pyrrolidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-3.17β-diol
4-chloro-11β-[4-[3-(1-piperidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-3.17β-diol
4-chloro-11β-[4-[3-(diethylamino)propyl]phenyl]-estra-1.3.5(10)-trien-3.17β-diol
17α-methy-11β-[4-[3-(1-piperidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-3.17β-diol,
4-chloro-17α-methyl-11β-[4-[3-(1-piperidinyl)propyl]phenyl]-estra-1.3.5(10)-trien-3.17β-diol,
11β-[4-[3-(1-piperidinyl)propyl]phenyl]-17α-(trifluoromethyl)-estra-1.3.5(10)-trien-3.17β-diol
(17R) 11β-[4-[3-(dimethylamino)propyl]phenyl]-spiro-(estra-1.3.5(10)-trien-17.2′(5′H)-furan)-3-ol
(17R) 4′,5′-dihydro-11β-[4-[3-(dimethylamino)propyl]phenyl]-spiro-(estra-1.3.5(10)-trien-17.2′(3′H)-furan)-3-ol.

### Claim 9 (depends on 1, 2)

9) Preparation process of the compounds of formula (I) as described in claim 1, in which a compound of formula (II) is submitted:
29
in which D and R2 are as described in claim 1 and K represents a protector group of the 3-ceto function, successive to the following reactions:
a) action of a compound of formula (III):
30
in which, M represents a metallic derivative, P represents a protector group, alcohol and n is an integer equal to 3, 4, or 5, then if need be deprotection of one or several protected reactive functions, in order to obtain a compound of formula (IIIa):
31
P′ having the same values as P as well as hydrogen,
b) action if need be, of a halogenation reagent, in order to obtain a formula (IIIb) compound:
32
Hal represents a halogen atom,
c) action of an aromatisation reagent of ring (A) on the compounds of formulas (IIIa) and (IIIb), after having, if need be, protected and/or activated the OH function, then action of a base to obtain the compound of formula (IV):
33
P″ having the same values as P′ and able to represent moreover an activating group,
X as described in claim 1,
d) action of an amine of formula (V):
34
R3 and R4 are as described in claim 1, this compound optionally being in the form of a salt, in order to obtain certain compounds of formula (I), the compounds of formulas (IIIa), (IIIb), (IV) and (I) being submitted if desired or necessary, in an appropriate order, to one or several of the following reactions:
protection/deprotection of the OH group(s),
alkylationlacylation of the OH group(s),
action of a reduction agent when D represents the residue of a pentagonal ring as described in claim 2 and R5 and R6 together form an oxo group,
action of an organometallic or CF3SiMe3 on the compounds of formula (IV) or (I) with D representing the residue of a pentagonal ring as described in claim 2 and R5 and R6 together form an oxo group,
action of a lactonisation agent on the compounds of formula (IV) or (I) with D representing the residue of a pentagonal ring as described in claim 2 and R5 and R6 together forming an oxo group,
action of a reduction agent of the double bond, when D represents the residue of a pentagonal ring as described in claim 2 and R5 and R6 together with the carbon that carries them, form a O—(CH2)1′—CH═CH— group,
action of a reduction agent of the double bond, when D represents the residue of a pentagonal ring as described in claim 2, and R6 is an alkenyl or alkynyl radical containing from 2 to 6 carbon atoms,
salification.

### Claim 10 (depends on 3, 9)

10) Preparation process according to claim 9, compounds of general formula (I′) as described in claim 3, in which a compound of formula (II′) is submitted:
35
in which K, R′5 and R′6 are as described in claim 3, or in which R′5 is a CN radical and R′6 is a protected hydroxyl, successive to the following reactions:
a) action of a formula (III′) compound:
36
in which M and P are as previously described, then deprotection of one or several protected reactive functions, in order to obtain a compound of formula (III′a):
37
b) action, if need be, of a halogenation reagent in order to obtain a formula (III′b) compound:
38
Hal′ representing a chlorine or bromine atom,
c) activation of the OH function then action of an aromatisation reagent of ring (A) on the compounds of formula (IIIa) or (IIIb), then action of a base to obtain the compounds of formula (IV′):
39
X′ and P″ are as described in claim 9,
d) action of a formula (V′) amine:
40
R′3 and R′4 are as previously described in order to obtain certain of the compounds of formula (I′), the compounds of formulas (III′a), (IIIb), (IV) (I) and (I′) being submitted, if desired or if necessary to one or several of the following reactions:
protection/deprotection of the OH group(s),
alkylation/acylation of the OH group(s),
action of a reduction agent when R′5 and R′6 together form an oxo group,
action of an organometallic or CF3SiMe3 on the compounds of formula (IV′) or (I′) with R′5 and R′6 together forming an oxo group,
action of a lactonisation agent on the compounds of formula (IV′) or (I′) with R′5 and R′6 together forming an oxo group,
action of a reduction agent of the double bond, when R′5 and R′6 together with the carbon that carries them, form an O—(CH2)1′—CH═CH— group,
action of a reduction agent of the double bond, when R′6 is an alkenyl or alkynyl radical containing from 2 to 6 carbon atoms,
salification.

### Claim 11 (depends on 1)

11) As medicines the compounds of formula (I) as described in claim 1, as well as their addition salts with pharmaceutically acceptable acids or the bases.

### Claim 12 (depends on 2, 3, 4, 5, 6, 7)

12) As medicines the compounds of formula (I) or (I′) as it is described in any of the claims 2 to 7, as well as their addition salts with pharmaceutically acceptable acids or bases.

### Claim 13 (depends on 8)

13) As medicines the compounds as they are described in claim 8 as well as their addition salts with pharmaceutically acceptable acids.

### Claim 14 (depends on 11, 12, 13)

14) Pharmaceutical compositions containing one or several of the medicines as described in any of the claims 11, 12 or 13.

### Claim 15 (depends on 9, 10)

15) As novel intermediate products, the compounds of general formulas (IIIa), (IIIb), (III′a), (III′b), (IV) or (IV′) as they are described in claims 9 or 10.
